The Digital Future of Diabetes Care

• Data analysis to help understand individual needs 

• Partnerships with digital experts 

• The potential of Artificial Intelligence  

At Sanofi, we believe in a personalized care approach at each stage of the diabetes journey, with the appropriate combination of treatments, education and technology.  We think that data analytics and technology can enhance diabetes medications, enabling physicians to generate better insights into the health of each individual person living with diabetes.  

By coupling data & technology with our comprehensive insulin-based portfolio, we hope to help people with diabetes achieve better health outcomes. However, we understand this is not an easy process to tackle alone. That is why we have established partnerships with different entities, such as Evidation and Dario, to better understand the needs of those living with diabetes, beyond their medication. It is in such topics like behavioral science and technology adoption where we see untapped opportunities to help diabetes management.  

The better we can understand and support the person above and beyond a specific health condition– accounting for their concerns, their challenges, their lives – the better we can aim to turn technology and digital health offerings into true miracles of science that help improve people’s lives. 

Could Artificial Intelligence change diabetes management? 

Another relevant topic for us at Sanofi is better understanding and maximizing the role that Artificial Intelligence (AI) could play in the future of personalized diabetes management. AI powered systems could be used to analyze the round-the-clock blood glucose data of millions of people, which could then be then tailored into advice and support decisions for each individual.  

As we look to the future of diabetes, we’re continuing to build on our holistic approach to helping bring diabetes under control through our comprehensive portfolio of solutions, including medicines, education programs, services, apps, and connected devices.  Our pledge to the diabetes community is: we won’t settle for less. 

We believe there is much potential for the future of diabetes care. By harnessing our 100 years of experience in insulin manufacturing and development, we are committed to helping shape the next 100 years. We aim to help change the way chronic diseases are controlled, not just with medicines, but with a holistic approach centered around peoples’ lives and well-being – powered by innovative digital technologies.